Clinical Trials Logo
  1. Home
  2. Neoplasia
  3. NCT02049658

The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients

Neoplasia Clinical Trial

Official title:
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients

Clinical Trial Summary

Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces. It is hypothesized that sniff dogs may be used as a tool in identifying cancer patients in the high risk population or suspected patients. Trained dogs will sniff serum from participants who are suspected to suffer from tumor by their physicians and not yet but will be diagnosed by pathological examination.The results will be compared with the outcome of the pathological examination.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02049658
Study type Observational
Source Central South University
Contact Chang-Qing Gao, MD PhD
Phone 86 188 7486 9488
Email cgao851@126.com
Status Recruiting
Phase
Start date January 2014
Completion date December 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT00339989 - Cervical Cancer Early Endpoints and Determinants
Completed NCT01954836 - Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial N/A
Not yet recruiting NCT03979014 - Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial Phase 3
Completed NCT02065297 - Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Recruiting NCT02049645 - The Suitability of Sniff Dog as a Tool in Screening Tumors
Completed NCT01523912 - Radiofrequency Ablation for the Treatment of Gastric Dysplasia Phase 4
Completed NCT03415126 - A Study of ASN007 in Patients With Advanced Solid Tumors Phase 1
Enrolling by invitation NCT00792649 - Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy N/A
Recruiting NCT05158712 - Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Completed NCT01962103 - Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Phase 1/Phase 2
Terminated NCT01456143 - Optical Imaging of Head and Neck Cancer N/A
Recruiting NCT04341181 - ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling Phase 2
Recruiting NCT02925234 - The Drug Rediscovery Protocol (DRUP Trial) Phase 2